Application of PBPK Modeling and Virtual Clinical Study Approaches to Predict the Outcomes of CYP2D6 Genotype‐Guided Dosing of Tamoxifen

The Tamoxifen Response by CYP2D6 Genotype‐based Treatment‐1 (TARGET‐1) study (n = 180) was conducted from 2012–2017 in Japan to determine the efficacy of tamoxifen dosing guided by cytochrome P450 2D6 (CYP2D6) genotypes. To predict its outcomes prior to completion, we constructed the comprehensive p...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Toshimichi, Toshimoto, Kota, Lee, Wooin, Imamura, Chiyo K., Tanigawara, Yusuke, Sugiyama, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063740/
https://www.ncbi.nlm.nih.gov/pubmed/29920987
http://dx.doi.org/10.1002/psp4.12307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063740/
https://www.ncbi.nlm.nih.gov/pubmed/29920987
http://dx.doi.org/10.1002/psp4.12307

Ejemplares similares